Further, EGFR signaling has been implicated in a spectrum of neurometabolic conditions, such as metabolic syndrome, diabetes, AD, cancer, and cardiorespiratory function (Siddiqui et al., 2012). This evidence concerns the gene EGFR and diabetes mellitus.